Found: 67
Select item for more details and to access through your institution.
Determinants of physiologic 18F-FDG uptake in brown adipose tissue in sequential PET/CT examinations.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Prognostic Relevance of Neutrophil to Lymphocyte Ratio (NLR) in Luminal Breast Cancer: A Retrospective Analysis in the Neoadjuvant Setting.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 7, p. 1685, doi. 10.3390/cells10071685
- By:
- Publication type:
- Article
Autoantibodies Specific to ERα are Involved in Tamoxifen Resistance in Hormone Receptor Positive Breast Cancer.
- Published in:
- Cells (2073-4409), 2019, v. 8, n. 7, p. 750, doi. 10.3390/cells8070750
- By:
- Publication type:
- Article
A nomogram to predict survival in non-small cell lung cancer patients treated with nivolumab.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Coexisting YAP expression and TP53 missense mutations delineates a molecular scenario unexpectedly associated with better survival outcomes in advanced gastric cancer.
- Published in:
- 2018
- By:
- Publication type:
- letter
Burnout of health care providers during the COVID-19 pandemic: Focus on Medical Oncologists.
- Published in:
- International Journal of Medical Sciences, 2021, v. 18, n. 10, p. 2235, doi. 10.7150/ijms.54025
- By:
- Publication type:
- Article
Second-line Eribulin in Triple Negative Metastatic Breast Cancer patients. Multicentre Retrospective Study: The TETRIS Trial.
- Published in:
- International Journal of Medical Sciences, 2021, v. 18, n. 10, p. 2245, doi. 10.7150/ijms.54996
- By:
- Publication type:
- Article
The Agnostic Role of Site of Metastasis in Predicting Outcomes in Cancer Patients Treated with Immunotherapy.
- Published in:
- Vaccines, 2020, v. 8, n. 2, p. 203, doi. 10.3390/vaccines8020203
- By:
- Publication type:
- Article
The Impact of Locoregional Treatment on Response to Nivolumab in Advanced Platinum Refractory Head and Neck Cancer: The Need Trial.
- Published in:
- Vaccines, 2020, v. 8, n. 2, p. 191, doi. 10.3390/vaccines8020191
- By:
- Publication type:
- Article
Lymph node fine needle cytology in the diagnosis of infectious diseases and instrumental guides: ultrasound and computed tomography.
- Published in:
- Infezioni in Medicina, 2012, p. 26
- By:
- Publication type:
- Article
Biomarkers of Response and Resistance to CDK4/6 Inhibitors in Breast Cancer: Hints from Liquid Biopsy and microRNA Exploration.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 23, p. 14534, doi. 10.3390/ijms232314534
- By:
- Publication type:
- Article
Neoadjuvant Endocrine Therapy in Breast Cancer: Current Knowledge and Future Perspectives.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 10, p. 3528, doi. 10.3390/ijms21103528
- By:
- Publication type:
- Article
PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world setting.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211059873
- By:
- Publication type:
- Article
Fulvestrant and trastuzumab in patients with luminal HER2-positive advanced breast cancer (ABC): an Italian real-world experience (HERMIONE 9).
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 190, n. 1, p. 103, doi. 10.1007/s10549-021-06371-9
- By:
- Publication type:
- Article
Antiandrogen therapy in metastatic male breast cancer: results from an updated analysis in an expanded case series.
- Published in:
- Breast Cancer Research & Treatment, 2014, v. 148, n. 1, p. 73, doi. 10.1007/s10549-014-3138-9
- By:
- Publication type:
- Article
Aromatase inhibitors for metastatic male breast cancer: molecular, endocrine, and clinical considerations.
- Published in:
- Breast Cancer Research & Treatment, 2014, v. 147, n. 2, p. 227, doi. 10.1007/s10549-014-3087-3
- By:
- Publication type:
- Article
Outcomes of HER2-positive early breast cancer patients in the pre-trastuzumab and trastuzumab eras: a real-world multicenter observational analysis. The RETROHER study.
- Published in:
- Breast Cancer Research & Treatment, 2014, v. 147, n. 3, p. 599, doi. 10.1007/s10549-014-3133-1
- By:
- Publication type:
- Article
Docetaxel, oxaliplatin, and capecitabine combination chemotherapy for metastatic gastric cancer.
- Published in:
- Gastric Cancer, 2014, v. 17, n. 4, p. 718, doi. 10.1007/s10120-013-0321-3
- By:
- Publication type:
- Article
Loss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual HER2 blockade: the SePHER Study.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2020, v. 39, n. 1, p. 1, doi. 10.1186/s13046-020-01797-3
- By:
- Publication type:
- Article
Assessment of metabolic activity by PET-CT with F-18-FDG in patients with T-cell lymphoma.
- Published in:
- British Journal of Haematology, 2010, v. 151, n. 2, p. 195, doi. 10.1111/j.1365-2141.2010.08335.x
- By:
- Publication type:
- Article
Prognostic value of [18F]-FDG PET/CT in patients with metastatic breast cancer treated with cyclin-dependent inhibitors.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1193174
- By:
- Publication type:
- Article
Pathologic response and survival after neoadjuvant chemotherapy with or without pertuzumab in patients with HER2-positive breast cancer: the Neopearl nationwide collaborative study.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1177681
- By:
- Publication type:
- Article
COVID‐19 risk in breast cancer patients receiving CDK4/6 inhibitors: literature data and a monocentric experience.
- Published in:
- Breast Journal, 2021, v. 27, n. 4, p. 359, doi. 10.1111/tbj.14204
- By:
- Publication type:
- Article
Trastuzumab‐related cardiotoxicity in patients with nonlimiting cardiac comorbidity.
- Published in:
- Breast Journal, 2019, v. 25, n. 3, p. 444, doi. 10.1111/tbj.13240
- By:
- Publication type:
- Article
Vitamin D Supplementation and Breast Cancer Prevention: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
- Published in:
- PLoS ONE, 2013, v. 8, n. 7, p. 1, doi. 10.1371/journal.pone.0069269
- By:
- Publication type:
- Article
HMG-CoAR expression in male breast cancer: relationship with hormone receptors, Hippo transducers and survival outcomes.
- Published in:
- Scientific Reports, 2016, p. 35121, doi. 10.1038/srep35121
- By:
- Publication type:
- Article
PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world setting.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211059873
- By:
- Publication type:
- Article
Prognostic relevance of DNA damage and repair biomarkers in elderly patients with hormone-receptor-positive breast cancer treated with neoadjuvant hormone therapy: evidence from the real-world setting.
- Published in:
- Therapeutic Advances in Medical Oncology, 2019, v. 11, p. 1, doi. 10.1177/1758835919853192
- By:
- Publication type:
- Article
Prognostic relevance of DNA damage and repair biomarkers in elderly patients with hormone-receptor-positive breast cancer treated with neoadjuvant hormone therapy: evidence from the real-world setting.
- Published in:
- Therapeutic Advances in Medical Oncology, 2019, v. 11, p. N.PAG, doi. 10.1177/1758835919853192
- By:
- Publication type:
- Article
Effectiveness of neoadjuvant trastuzumab and chemotherapy in HER2-overexpressing breast cancer.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2013, v. 139, n. 7, p. 1229, doi. 10.1007/s00432-013-1436-y
- By:
- Publication type:
- Article
The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-92774-z
- By:
- Publication type:
- Article
Deep sequencing and pathway-focused analysis revealed multigene oncodriver signatures predicting survival outcomes in advanced colorectal cancer.
- Published in:
- Oncogenesis, 2018, v. 7, n. 7, p. 1, doi. 10.1038/s41389-018-0066-2
- By:
- Publication type:
- Article
The Role of the CDK4/6 Inhibitor Ribociclib in Locally Advanced and Oligometastatic Hormone Receptor Positive, Her2 Negative, Advanced Breast Cancer: Case Series and Review of the Literature.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.797157
- By:
- Publication type:
- Article
DNA Damage Response in Early Breast Cancer: A Phase III Cohort in the Phobos Study.
- Published in:
- Cancers, 2024, v. 16, n. 15, p. 2628, doi. 10.3390/cancers16152628
- By:
- Publication type:
- Article
The Impact of the Hippo Pathway and Cell Metabolism on Pathological Complete Response in Locally Advanced Her2+ Breast Cancer: The TRISKELE Multicenter Prospective Study.
- Published in:
- Cancers, 2022, v. 14, n. 19, p. 4835, doi. 10.3390/cancers14194835
- By:
- Publication type:
- Article
Role of Chemotherapy in Vulvar Cancers: Time to Rethink Standard of Care?
- Published in:
- Cancers, 2021, v. 13, n. 16, p. 4061, doi. 10.3390/cancers13164061
- By:
- Publication type:
- Article
CDK4/6 Inhibitor Treatments in Patients with Hormone Receptor Positive, Her2 Negative Advanced Breast Cancer: Potential Molecular Mechanisms, Clinical Implications and Future Perspectives.
- Published in:
- Cancers, 2021, v. 13, n. 2, p. 332, doi. 10.3390/cancers13020332
- By:
- Publication type:
- Article
Neoadjuvant Immune-Checkpoint Blockade in Triple-Negative Breast Cancer: Current Evidence and Literature-Based Meta-Analysis of Randomized Trials.
- Published in:
- Cancers, 2020, v. 12, n. 9, p. 2497, doi. 10.3390/cancers12092497
- By:
- Publication type:
- Article
Observational Multicenter Study on the Prognostic Relevance of Coagulation Activation in Risk Assessment and Stratification in Locally Advanced Breast Cancer. Outline of the ARIAS Trial.
- Published in:
- Cancers, 2020, v. 12, n. 4, p. 849, doi. 10.3390/cancers12040849
- By:
- Publication type:
- Article
Letrozole combined with gonadotropin-releasing hormone analog for metastatic male breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2013, v. 141, n. 1, p. 119, doi. 10.1007/s10549-013-2675-y
- By:
- Publication type:
- Article
Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real‐world evidence.
- Published in:
- Journal of Cellular Physiology, 2020, v. 235, n. 11, p. 7900, doi. 10.1002/jcp.29445
- By:
- Publication type:
- Article
Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor‐positive, advanced breast cancer: A real‐world experience.
- Published in:
- Journal of Cellular Physiology, 2019, v. 234, n. 6, p. 7708, doi. 10.1002/jcp.27832
- By:
- Publication type:
- Article
Neoadjuvant chemotherapy in triple-negative breast cancer: A multicentric retrospective observational study in real-life setting.
- Published in:
- Journal of Cellular Physiology, 2018, v. 233, n. 3, p. 2313, doi. 10.1002/jcp.26103
- By:
- Publication type:
- Article
GLUT 1 receptor expression and circulating levels of fasting glucose in high grade serous ovarian cancer.
- Published in:
- Journal of Cellular Physiology, 2018, v. 233, n. 2, p. 1396, doi. 10.1002/jcp.26023
- By:
- Publication type:
- Article
Association between AXL, Hippo Transducers, and Survival Outcomes in Male Breast Cancer.
- Published in:
- Journal of Cellular Physiology, 2017, v. 232, n. 8, p. 2246, doi. 10.1002/jcp.25745
- By:
- Publication type:
- Article
Neoadjuvant Sequential Docetaxel Followed by High-Dose Epirubicin in Combination With Cyclophosphamide Administered Concurrently With Trastuzumab. The DECT Trial.
- Published in:
- Journal of Cellular Physiology, 2016, v. 231, n. 11, p. 2541, doi. 10.1002/jcp.25432
- By:
- Publication type:
- Article
Body Mass Index and Treatment Outcomes in Metastatic Breast Cancer Patients Treated With Eribulin.
- Published in:
- Journal of Cellular Physiology, 2016, v. 231, n. 5, p. 986, doi. 10.1002/jcp.25213
- By:
- Publication type:
- Article
Anthropometric, Metabolic and Molecular Determinants of Human Epidermal Growth Factor Receptor 2 Expression in Luminal B Breast Cancer.
- Published in:
- Journal of Cellular Physiology, 2015, v. 230, n. 8, p. 1708, doi. 10.1002/jcp.24891
- By:
- Publication type:
- Article
Circulating HPV DNA in the Management of Oropharyngeal and Cervical Cancers: Current Knowledge and Future Perspectives.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 7, p. 1525, doi. 10.3390/jcm10071525
- By:
- Publication type:
- Article
Long-Term Safety and Real-World Effectiveness of Trastuzumab in Breast Cancer.
- Published in:
- Journal of Clinical Medicine, 2019, v. 8, n. 2, p. 254, doi. 10.3390/jcm8020254
- By:
- Publication type:
- Article